Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mg
Clinical trial NCT02753803 · COMPLETED
Trial details
- NCT number
- NCT02753803
- Sponsor
- Dong-A ST Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-27
- Primary completion
- 2016-10-19
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.